Report Detail
Global Radioactive Therapeutic Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM4569463 |
- 08 December, 2023 |
- Global |
- 100 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Radioactive Therapeutic Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
Nuclear medicine therapy uses radiopharmaceuticals targeting specific tumors, such as thyroid tumors, lymphomas, or bone metastases, to deliver radiation to neoplastic lesions as part of a therapeutic strategy to cure, alleviate, or control the disease.
The Global Info Research report includes an overview of the development of the Radioactive Therapeutic Drugs industry chain, the market status of Hospitals (Oncology, Cardiology), Academic & Research Institutes (Oncology, Cardiology), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Radioactive Therapeutic Drugs.
Regionally, the report analyzes the Radioactive Therapeutic Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Radioactive Therapeutic Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Radioactive Therapeutic Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Radioactive Therapeutic Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Oncology, Cardiology).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Radioactive Therapeutic Drugs market.
Regional Analysis: The report involves examining the Radioactive Therapeutic Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Radioactive Therapeutic Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Radioactive Therapeutic Drugs:
Company Analysis: Report covers individual Radioactive Therapeutic Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Radioactive Therapeutic Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Academic & Research Institutes).
Technology Analysis: Report covers specific technologies relevant to Radioactive Therapeutic Drugs. It assesses the current state, advancements, and potential future developments in Radioactive Therapeutic Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Radioactive Therapeutic Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Radioactive Therapeutic Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Oncology
Cardiology
Others
Market segment by Application
Hospitals
Academic & Research Institutes
Others
Market segment by players, this report covers
Nihon Medi-Physics
ITM Isotopen Technologien München AG
Advanced Accelerator Applications
Telix Pharmaceuticals
GE Healthcare
Theragnostics Ltd.
NuView Life Sciences
Jubilant Pharma Limited
Lantheus Holdings, Inc.
Curium Pharma
Bayer AG
Clarity Pharmaceuticals
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Radioactive Therapeutic Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Radioactive Therapeutic Drugs, with revenue, gross margin and global market share of Radioactive Therapeutic Drugs from 2018 to 2023.
Chapter 3, the Radioactive Therapeutic Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Radioactive Therapeutic Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Radioactive Therapeutic Drugs.
Chapter 13, to describe Radioactive Therapeutic Drugs research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Radioactive Therapeutic Drugs
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Radioactive Therapeutic Drugs by Type
- 1.3.1 Overview: Global Radioactive Therapeutic Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Radioactive Therapeutic Drugs Consumption Value Market Share by Type in 2022
- 1.3.3 Oncology
- 1.3.4 Cardiology
- 1.3.5 Others
- 1.4 Global Radioactive Therapeutic Drugs Market by Application
- 1.4.1 Overview: Global Radioactive Therapeutic Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospitals
- 1.4.3 Academic & Research Institutes
- 1.4.4 Others
- 1.5 Global Radioactive Therapeutic Drugs Market Size & Forecast
- 1.6 Global Radioactive Therapeutic Drugs Market Size and Forecast by Region
- 1.6.1 Global Radioactive Therapeutic Drugs Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Radioactive Therapeutic Drugs Market Size by Region, (2018-2029)
- 1.6.3 North America Radioactive Therapeutic Drugs Market Size and Prospect (2018-2029)
- 1.6.4 Europe Radioactive Therapeutic Drugs Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Radioactive Therapeutic Drugs Market Size and Prospect (2018-2029)
- 1.6.6 South America Radioactive Therapeutic Drugs Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Radioactive Therapeutic Drugs Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 Nihon Medi-Physics
- 2.1.1 Nihon Medi-Physics Details
- 2.1.2 Nihon Medi-Physics Major Business
- 2.1.3 Nihon Medi-Physics Radioactive Therapeutic Drugs Product and Solutions
- 2.1.4 Nihon Medi-Physics Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Nihon Medi-Physics Recent Developments and Future Plans
- 2.2 ITM Isotopen Technologien München AG
- 2.2.1 ITM Isotopen Technologien München AG Details
- 2.2.2 ITM Isotopen Technologien München AG Major Business
- 2.2.3 ITM Isotopen Technologien München AG Radioactive Therapeutic Drugs Product and Solutions
- 2.2.4 ITM Isotopen Technologien München AG Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 ITM Isotopen Technologien München AG Recent Developments and Future Plans
- 2.3 Advanced Accelerator Applications
- 2.3.1 Advanced Accelerator Applications Details
- 2.3.2 Advanced Accelerator Applications Major Business
- 2.3.3 Advanced Accelerator Applications Radioactive Therapeutic Drugs Product and Solutions
- 2.3.4 Advanced Accelerator Applications Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Advanced Accelerator Applications Recent Developments and Future Plans
- 2.4 Telix Pharmaceuticals
- 2.4.1 Telix Pharmaceuticals Details
- 2.4.2 Telix Pharmaceuticals Major Business
- 2.4.3 Telix Pharmaceuticals Radioactive Therapeutic Drugs Product and Solutions
- 2.4.4 Telix Pharmaceuticals Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Telix Pharmaceuticals Recent Developments and Future Plans
- 2.5 GE Healthcare
- 2.5.1 GE Healthcare Details
- 2.5.2 GE Healthcare Major Business
- 2.5.3 GE Healthcare Radioactive Therapeutic Drugs Product and Solutions
- 2.5.4 GE Healthcare Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 GE Healthcare Recent Developments and Future Plans
- 2.6 Theragnostics Ltd.
- 2.6.1 Theragnostics Ltd. Details
- 2.6.2 Theragnostics Ltd. Major Business
- 2.6.3 Theragnostics Ltd. Radioactive Therapeutic Drugs Product and Solutions
- 2.6.4 Theragnostics Ltd. Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Theragnostics Ltd. Recent Developments and Future Plans
- 2.7 NuView Life Sciences
- 2.7.1 NuView Life Sciences Details
- 2.7.2 NuView Life Sciences Major Business
- 2.7.3 NuView Life Sciences Radioactive Therapeutic Drugs Product and Solutions
- 2.7.4 NuView Life Sciences Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 NuView Life Sciences Recent Developments and Future Plans
- 2.8 Jubilant Pharma Limited
- 2.8.1 Jubilant Pharma Limited Details
- 2.8.2 Jubilant Pharma Limited Major Business
- 2.8.3 Jubilant Pharma Limited Radioactive Therapeutic Drugs Product and Solutions
- 2.8.4 Jubilant Pharma Limited Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Jubilant Pharma Limited Recent Developments and Future Plans
- 2.9 Lantheus Holdings, Inc.
- 2.9.1 Lantheus Holdings, Inc. Details
- 2.9.2 Lantheus Holdings, Inc. Major Business
- 2.9.3 Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Product and Solutions
- 2.9.4 Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Lantheus Holdings, Inc. Recent Developments and Future Plans
- 2.10 Curium Pharma
- 2.10.1 Curium Pharma Details
- 2.10.2 Curium Pharma Major Business
- 2.10.3 Curium Pharma Radioactive Therapeutic Drugs Product and Solutions
- 2.10.4 Curium Pharma Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Curium Pharma Recent Developments and Future Plans
- 2.11 Bayer AG
- 2.11.1 Bayer AG Details
- 2.11.2 Bayer AG Major Business
- 2.11.3 Bayer AG Radioactive Therapeutic Drugs Product and Solutions
- 2.11.4 Bayer AG Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 Bayer AG Recent Developments and Future Plans
- 2.12 Clarity Pharmaceuticals
- 2.12.1 Clarity Pharmaceuticals Details
- 2.12.2 Clarity Pharmaceuticals Major Business
- 2.12.3 Clarity Pharmaceuticals Radioactive Therapeutic Drugs Product and Solutions
- 2.12.4 Clarity Pharmaceuticals Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
- 2.12.5 Clarity Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Radioactive Therapeutic Drugs Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Radioactive Therapeutic Drugs by Company Revenue
- 3.2.2 Top 3 Radioactive Therapeutic Drugs Players Market Share in 2022
- 3.2.3 Top 6 Radioactive Therapeutic Drugs Players Market Share in 2022
- 3.3 Radioactive Therapeutic Drugs Market: Overall Company Footprint Analysis
- 3.3.1 Radioactive Therapeutic Drugs Market: Region Footprint
- 3.3.2 Radioactive Therapeutic Drugs Market: Company Product Type Footprint
- 3.3.3 Radioactive Therapeutic Drugs Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Radioactive Therapeutic Drugs Consumption Value and Market Share by Type (2018-2023)
- 4.2 Global Radioactive Therapeutic Drugs Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global Radioactive Therapeutic Drugs Consumption Value Market Share by Application (2018-2023)
- 5.2 Global Radioactive Therapeutic Drugs Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America Radioactive Therapeutic Drugs Consumption Value by Type (2018-2029)
- 6.2 North America Radioactive Therapeutic Drugs Consumption Value by Application (2018-2029)
- 6.3 North America Radioactive Therapeutic Drugs Market Size by Country
- 6.3.1 North America Radioactive Therapeutic Drugs Consumption Value by Country (2018-2029)
- 6.3.2 United States Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
- 6.3.3 Canada Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Radioactive Therapeutic Drugs Consumption Value by Type (2018-2029)
- 7.2 Europe Radioactive Therapeutic Drugs Consumption Value by Application (2018-2029)
- 7.3 Europe Radioactive Therapeutic Drugs Market Size by Country
- 7.3.1 Europe Radioactive Therapeutic Drugs Consumption Value by Country (2018-2029)
- 7.3.2 Germany Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
- 7.3.3 France Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
- 7.3.5 Russia Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
- 7.3.6 Italy Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Radioactive Therapeutic Drugs Consumption Value by Type (2018-2029)
- 8.2 Asia-Pacific Radioactive Therapeutic Drugs Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific Radioactive Therapeutic Drugs Market Size by Region
- 8.3.1 Asia-Pacific Radioactive Therapeutic Drugs Consumption Value by Region (2018-2029)
- 8.3.2 China Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
- 8.3.3 Japan Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
- 8.3.5 India Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
- 8.3.7 Australia Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Radioactive Therapeutic Drugs Consumption Value by Type (2018-2029)
- 9.2 South America Radioactive Therapeutic Drugs Consumption Value by Application (2018-2029)
- 9.3 South America Radioactive Therapeutic Drugs Market Size by Country
- 9.3.1 South America Radioactive Therapeutic Drugs Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Radioactive Therapeutic Drugs Consumption Value by Type (2018-2029)
- 10.2 Middle East & Africa Radioactive Therapeutic Drugs Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa Radioactive Therapeutic Drugs Market Size by Country
- 10.3.1 Middle East & Africa Radioactive Therapeutic Drugs Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
- 10.3.4 UAE Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Radioactive Therapeutic Drugs Market Drivers
- 11.2 Radioactive Therapeutic Drugs Market Restraints
- 11.3 Radioactive Therapeutic Drugs Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Radioactive Therapeutic Drugs Industry Chain
- 12.2 Radioactive Therapeutic Drugs Upstream Analysis
- 12.3 Radioactive Therapeutic Drugs Midstream Analysis
- 12.4 Radioactive Therapeutic Drugs Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Radioactive Therapeutic Drugs. Industry analysis & Market Report on Radioactive Therapeutic Drugs is a syndicated market report, published as Global Radioactive Therapeutic Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Radioactive Therapeutic Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
